Atlas Trials

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

Clinical trial NCT06904859 · COMPLETED

Trial details

NCT number
NCT06904859
Sponsor
Shenzhen University General Hospital
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2019-01-01
Primary completion
2019-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.